Targeted degradation of a‐synuclein via the AdPROM system prevents PFF‐induced a‐synuclein aggregation

Bill Carton, Géraldine Gelders, Nur Kocaturk, Sascha Roth, Thomas Macartney, Joke Van Elsen, Louis De Muynck, Arjan Buist, Diederik Moechars, Gopal Sapkota · 2025

Read Targeted degradation of a‐synuclein via the AdPROM system prevents PFF‐induced a‐synuclein aggregation by Bill Carton, Géraldine Gelders, Nur Kocaturk, Sascha Roth, Thomas Macartney, Joke Van Elsen, Louis De Muynck, Arjan Buist, Diederik Moechars, Gopal Sapkota (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713927.txt.

Description

Bill Carton and co-authors report in 2025 a method for clearing a clumped protein tied to Parkinson disease and related disorders from cells. Buildup of this protein in brain cells drives those diseases, which still have no treatment that changes their course. Their system joins a cell disposal tag with a tiny antibody that picks out the human form of the protein.

In human cell lines, the system removed the target protein with high selectivity. In rat neurons that make the human protein, clearing it first blocked later clumping triggered by added fibrils. The authors note that work in live mice is in progress. Readers see a targeted disposal route that may one day be tested as therapy.

Catalog record

CREATORBill Carton, Géraldine Gelders, Nur Kocaturk, Sascha Roth, Thomas Macartney, Joke Van Elsen, Louis De Muynck, Arjan Buist, Diederik Moechars, Gopal Sapkota
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11713927

Browse the full library · About the Tower of Babel